Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Talampanel in Treating Patients With Recurrent High-Grade Glioma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: July 8, 2003
Last updated: March 7, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Estimated Primary Completion Date: No date given